Background and Purpose-The fractalkine ligand/receptor (CX3CL1/CX3CR1) complex is important in inflammatory responses and has been associated with vascular disease. We determined whether genetic variants in CX3CL1 and CX3CR1 are associated with carotid atherosclerosis in 2 large European populations. Methods-18 polymorphisms in CX3CL1 and CX3CR1 were genotyped in 2763 German community individuals (CAPS). Positive results were tested for replication on 6049 French community individuals (3C Study). Results-In CAPS we found associations of common carotid artery (CCA)-IMT with 2 CX3CL1 (rs170364, rs614230) and 1 CX3CR1 (rs3732378) variants, and significant interactions of CX3CR1 rs11129820, rs3732378, and rs614230 variants with smoking and alcohol consumption in relation with CCA-IMT. None of these were replicated in 3C. In 3C only there was a borderline significant association of rs3732378 with carotid plaques. Conclusion-In almost 9000 subjects, we found no replicable associations of CX3CL1 and CX3CR1 polymorphisms with CCA-IMT or plaque. (Stroke. 2009;40:00-00.)
R
ecently proinflammatory variants in genes encoding inflammatory responses have been implicated as risk factors for carotid atherosclerosis, acting synergistically with proinflammatory conventional risk factors. 1 In this study we focused on 2 candidate genes, encoding fractalkine (CX3CL1) and its receptor (CX3CR1). This chemokine receptor-ligand complex is a key component of leukocyte trafficking and the interaction of CX3CL1 with CX3CR1 facilitates the infiltration of monocytes, T-cells, and smooth muscle cells into atherosclerotic lesions. 2 We determined associations, including gene-environment interactions, of CX3CL1 and CX3CR1 genetic variants with carotid intima-media thickness (IMT) and plaque in a community population of middle-aged German subjects, the Carotid Atherosclerosis Progression Study (CAPS). 3 Subsequently we assessed whether positive results could be replicated in a population-based sample of elderly French subjects, the Three-City Study (3C). 4 
Methods
Details on the CAPS and 3C populations, clinical variables, and ultrasound protocols have been published previously 3, 4 (supplemental data, available online at http://stroke.ahajournals.org). The present analysis comprised 2763 and 6049 community individuals for CAPS and 3C, respectively. Centralized IMT measurements of the common carotid artery (CCA) were performed for both studies. Carotid plaque was defined as a focal region of IMT thickening Ͼ1.7 mm in CAPS, and Ն1 mm in 3C.
Eighteen polymorphisms to be tested in CAPS were chosen from dbSNP (http://www.ncbi.nlm.nih.gov/sites/entrez) and Hapmap (http://www.hapmap.org/index.html.en) and genotyping was performed by K-Bioscience (www.kbioscience.co.uk, see supplemental data).
Statistical analyses were performed with the SAS 8.02 software package (SAS Institute Inc). Estimation of linkage disequilibrium (LD) between SNPs and haplotype analyses were performed with the THESIAS program. 5 For the initial study we used a threshold of PϽ0.05 to not miss associations. In the replication study we used a Bonferroni correction to control for the number of variants tested; this was 5, therefore the probability value was 0.01.
Results
Principal characteristics of the populations are shown in Table 1 . All vascular risk factors were significantly associated with carotid plaque and CCA-IMT (data not shown). All tested SNPs were in Hardy-Weinberg equilibrium and allelic frequencies fell within the range reported in previous studies.
CAPS
Associations of the 18 SNPs in CX3CL1 and CX3CR1 with CCA-IMT are shown in Table 2 . Carriers of the rare allele of rs170364, rs614230, and rs3732378 had a significantly higher CCA-IMT (Table 2) . Results were similar after excluding subjects with carotid plaque (data not shown); this was tested because in 3C CCA-IMT was measured at a site free of plaques.
Haplotype analysis was performed for rs170364 and rs614230 (CX3CL1) and for rs3732378 and rs3732379 (CX3CR1), respectively in strong LD (DЈϭ0.99 and DЈϭ0.98). No individual haplotype was significantly associated with CCA-IMT (supplemental Table I , available online at http://stroke.ahajournals.org).
There was no association with carotid plaques, or with IMT at any location Ն1 mm (supplemental Table II) .
In relation with CCA-IMT there was a significant interaction of smoking with rs11129820 (Pϭ0.004) and rs3732378 (Pϭ0.005), of alcohol consumption with rs614230 (Pϭ0.009) and rs3732378 (Pϭ0.0003), and of CRP-level with rs11129820 (PϽ0.0001). Analyses stratified on these proinflammatory risk factors are shown in supplemental Table III . There was no interaction between rs3732378 and rs170364 or rs614230.
3C Study
Five SNPs were selected for replication in 3C: 4 because they were associated with CCA-IMT on the primary or interaction analysis in CAPS (rs170364, rs614230, rs3732378, rs11129820), and 1 (rs3732379) because it was always studied together with rs3732378. 6 -8 No association with CCA-IMT was found on primary analysis (supplemental Table IV ) or on analysis of geneenvironment interactions (data not shown).
There was a borderline significant increase of carotid plaque frequency in carriers of the rs3732378 rare variant (Table 3) .
Stratifying on age (Ͼversus Յmedian), hypertension, hypercholesterolemia, diabetes, BMI, or alcohol consumption did not change the results in 3C (data not shown).
Discussion
In a large population-based sample (CAPS), we found associations of CCA-IMT with 3 genetic variants in CX3CL1 SE indicates standard error; *recessive model; †dominant model; ‡analysis of covariance adjusted for age and gender; §and additionally for history of hypertension; pack-years of smoking, diabetes, LDL-cholesterol, BMI, and alcohol consumption; SNPs in bold are those that were selected for the replication study. (rs170364, rs614230) and CX3CR1 (rs3732378), and several significant interactions with proinflammatory risk factors in relation with CCA-IMT. However none of these were replicated in another large population-based study (3C). In 3C, although rs3732378 was not associated with IMT, it showed a borderline significant association with carotid plaque.
One previous study found an inverse association of rs3732379 with carotid IMT progression in 141 HIVpatients. 7 We did not find any association of IMT with rs3732379, although we did not measure IMT progression. Another study observed a decreased CCA-IMT in homozygous rs3732378-variant carriers among 1256 individuals. 6 The association of rs3732378 with CCA-IMT in CAPS was in the opposite direction, and not replicated in 3C, thus suggesting the absence of a genuine association.
We cannot formally exclude that the modest association of rs3732378 with carotid plaque observed in 3C only is real, as the power to detect an association with carotid plaque in CAPS was lower. However, our results suggest that, if it exists, it must be weak. CX3CL1/CX3CR1 variants have not been previously tested in association with carotid plaque. An increased risk of ischemic stroke was described in rs3732378-variant carriers 8 ; it is possible, however, that such an association is mediated by genetic factors which do not influence IMT. IMT, plaque, and stroke, although they share many risks factors, are distinct phenotypes.
IMT and plaque measurements differed between CAPS and 3C, but have both been validated and shown to be reproducible. 3, 4 The major differences were that in 3C IMT was measured in CCA without carotid plaque, and plaque was defined by a smaller cut-off (1 mm). However, removing subjects with plaque from the analysis with IMT, or using IMT-values Ն1 mm in any location to define plaque in CAPS, yielded similar results. Because of the more advanced age in 3C the higher prevalence of risk factors such as hypertension or hypercholesterolemia may have concealed the effect of genetic risk factors on CCA-IMT. However, results were unchanged after adjusting for and stratifying on age, hypertension, and hypercholesterolemia. Finally, although community-based, both cohorts are not perfectly representative of the general population as bias may occur in those subjects who agree to participate.
In conclusion, in a total of almost 9000 community individuals we found no replicable association of CX3CL1 and CX3CR1 genetic variants with markers of carotid atherosclerosis. This emphasizes the importance of primary replication of positive associations before publication.
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Supplemental Data on Methodological Issues Study Population
Details of the CAPS population have been published previously. 1 Briefly, all members of a German primary healthcare scheme (nϭ32 708), in 5 study sites in Western Germany, were invited to participate. Within a predefined time limit, 6962 people (21.3%) agreed to take part. For the present analysis, the first 2763 consecutive subjects who underwent ultrasound examination at baseline and with available DNA were included (we performed a large amount of genotyping and wanted to ensure best value for money; we therefore performed power calculations to determine the sample size we would require and then used samples from the first consecutive individuals to take us to that number to avoid any selection bias).
Details of the 3C population have been published before. 2 Briefly, 9693 noninstitutionalized persons aged Ն65 years were recruited from the electoral rolls of 3 French cities (Bordeaux, Dijon, Montpellier). 3 Among the eligible persons who could be contacted, the acceptance rate was 37%. For the present analysis we included the 6049 subjects who underwent a baseline ultrasound examination of the carotid arteries, with available DNA and whose native language was French, to reduce stratification bias.
Both studies are probably not perfectly representative of the general population, as persons who participate in a follow-up study are likely to be more health conscious and might have less risk factors and diseases than nonparticipants. 3 Besides, in the 3C-Study only noninstitutionalized individuals who were able to come to the study examination centers, and were thus probably in better health than the average population at the same age, were included.
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Definition of Clinical and Demographical Variables
In both studies, information about demographic background, medical history, and personal habits was collected during a face-to-face interview using a standardized questionnaire. Hypertension was defined according to the WHO criteria by either a current blood pressure-lowering therapy or a systolic blood pressure Ն160 mm Hg or a diastolic blood pressure Ն95 mm Hg on 2 separate measures performed at baseline. Body mass index (BMI) was calculated from baseline height and weight measures.
Centralized measurements of fasting total cholesterol, HDLcholesterol, triglyceride, and glucose levels were performed at baseline. LDL-cholesterol was calculated according to the Friedewald formula (LDLϭtotal cholesterol Ϫ HDL Ϫ [triglycerides/ 5]) and was considered as missing for triglyceride values Ͼ4.5 mmol/l. Hypercholesterolemia was defined as a total cholesterol Ն6.20 mmol/L and/or a cholesterol lowering therapy, diabetes mellitus as a fasting glucose Ͼ7 mmol/L, or a diabetes therapy.
Carotid Ultrasound Protocol
Ultrasound examinations performed in the CAPS and the 3C-Study were described in detail previously. 4, 5 For the CAPS examinations were performed with a 7.5-to 10.0-MHz linear array transducer (P700SE; Phillips Medical System). Using antero-oblique insonation, far-wall carotid IMT was visualized bilaterally at 3 sites: the common carotid artery (CCA-IMT, 20 -60 mm proximally from the flow divider), the carotid bifurcation (BIF-IMT, 0 -20 mm proximally from the flow divider), and the internal carotid artery bulb (ICA-IMT, 0 -20 mm distally from the flow divider). The images were digitally captured during the systole of a single heartbeat for offline measurement. Carotid IMT measurements were performed offline using automated imaging processing software (Matlab, The Mathworks Inc). The presence of carotid plaque was defined as a focal region of IMT thickening of Ͼ1.7 mm.
For the 3C-Study, B-mode imaging was performed with a 5-10 MHz transducer (Ultramark 9 High Definition Imaging). For IMT measurement, far and near walls of the right and the left CCA 20 -30 mm proximal to the bifurcation were imaged. For each side, at least 1 longitudinal image was captured in end-diastole by electrocardiogram R-triggering. All frozen images were transferred to a computer system (Iô TEC), digitized, and sent to the reference center where blinded offline analysis of all images was performed. CCA-IMT was measured at a site free of any discrete plaques along a 10-mm-long segment of the far wall. On average, 75 measurements were automatically performed on each image and each side and a mean CCA-IMT value was computed. In addition, the near and far walls of the common carotid arteries, the carotid bifurcations, and the origin of the internal carotid arteries were scanned longitudinally and transversally to assess, at the time of the examination, the presence of plaque. Carotid plaque was defined as a localized echo structure encroaching into the vessel lumen with a distance between the media-adventitia interface and the internal side of the lesion Ն1 mm.
Genetic Analyses
We mainly chose polymorphisms that were previously found to be associated with vascular disease 6 -19 and tag-SNPs. All known nonsynonymous SNPs in coding regions were included, as well as SNPs in noncoding regions (including the 5Ј-and 3Ј-UTR), to provide good coverage of the 2 genes. The genotyping was performed by KBioscience (www.kbioscience.co.uk) using a patent protected system (KSAPar). For CAPS the genotype call rate was 87% for one SNP (rs2853712) and Ͼ90% for all other SNPs. For the 3C Study the genotype call rate was Ͼ97% for the 5 SNPs that were studied. SE indicates standard error; *P value for a recessive model; †P value for a dominant model; ‡P value for interaction, tested in a multivariable general model (11, 10, 00); all models are analyses of covariance adjusted for age, gender, history of hypertension, pack-years of smoking, diabetes, LDL-cholesterol, BMI, and alcohol consumption; §median of the distribution. SE indicates standard error; *P value for a recessive model; †P value for a dominant model; both models are analyses of covariance adjusted for age, gender, history of hypertension, pack-years of smoking, diabetes, LDL-cholesterol, body mass index, alcohol consumption, and center.
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